• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷尼替丁对由最大压力期所测定的胃十二指肠运动的影响。

The effect of ranitidine on the gastroduodenal motility as determined by the maximal pressure periods.

作者信息

Myren J, Osnes M, Larsen S, Hansen T, Ness K

出版信息

Scand J Gastroenterol. 1986 Aug;21(6):733-6. doi: 10.3109/00365528609011109.

DOI:10.3109/00365528609011109
PMID:3529362
Abstract

Twenty healthy subjects with a mean age of 23.5 years were studied. Identically appearing tablets of 150 mg ranitidine or placebo were given to each subject twice daily for 2 days. After an overnight fast the same dosage of tablets was given 2 h before introduction of two fiberoptic transducers, the tips of which were localized to the mid-portion of the gastric antrum and the upper third of the duodenum. The double-blind crossover study showed in the placebo period a mean duration of the maximal pressure periods (MPP) of 5.5 min in the duodenum and 3.5 min in the antrum of the stomach. The cyclic length (CL) and the cyclic displacement (CD) in the duodenum were 58 min and 67 mm/min, respectively. After ranitidine the duration of the MPP was significantly longer. The CL was also longer in the duodenum, whereas the CD was shortened, indicating a reduction of the wave movements from the stomach antrum to the duodenum in the ranitidine periods.

摘要

对20名平均年龄为23.5岁的健康受试者进行了研究。给每位受试者每日两次服用外观相同的150毫克雷尼替丁片剂或安慰剂,持续2天。经过一夜禁食后,在插入两个光纤换能器前2小时给予相同剂量的片剂,换能器尖端分别置于胃窦中部和十二指肠上三分之一处。双盲交叉研究显示,在安慰剂期,十二指肠最大压力期(MPP)的平均持续时间为5.5分钟,胃窦为3.5分钟。十二指肠的周期长度(CL)和周期位移(CD)分别为58分钟和67毫米/分钟。服用雷尼替丁后,MPP的持续时间显著延长。十二指肠的CL也更长,而CD缩短,这表明在雷尼替丁治疗期间,从胃窦到十二指肠的波动减少。

相似文献

1
The effect of ranitidine on the gastroduodenal motility as determined by the maximal pressure periods.雷尼替丁对由最大压力期所测定的胃十二指肠运动的影响。
Scand J Gastroenterol. 1986 Aug;21(6):733-6. doi: 10.3109/00365528609011109.
2
Gastric motility following peroral administration of ranitidine. A double-blind comparison with placebo.
Scand J Gastroenterol Suppl. 1984;92:20-4.
3
[Protective effect of ranitidine in the stomach and duodenum against piroxicam. An endoscopy controlled double-blind study].
Arzneimittelforschung. 1992 Dec;42(12):1492-4.
4
Role of endogenous nitric oxide in regulating antropyloroduodenal motility in humans.内源性一氧化氮在调节人体胃幽门十二指肠运动中的作用。
Am J Gastroenterol. 2002 Jul;97(7):1661-7. doi: 10.1111/j.1572-0241.2002.05824.x.
5
Coordinated motor activity of the human gastroduodenal region.人类胃十二指肠区域的协调性运动活动。
Dig Dis Sci. 1985 Mar;30(3):219-24. doi: 10.1007/BF01347887.
6
Sonographic observations of the gastroduodenal junction in neonatal piglets.
Ultrasound Med Biol. 1998 Nov;24(9):1337-44. doi: 10.1016/s0301-5629(98)00113-6.
7
Gastroduodenal motility during the delayed gastric emptying induced by cold stress.冷应激诱导胃排空延迟期间的胃十二指肠运动
Gastroenterology. 1990 May;98(5 Pt 1):1155-61. doi: 10.1016/0016-5085(90)90328-x.
8
Normal and disturbed motility pattern in the duodenum of man. The effect of l-hyoscyamine, trimipramine and ranitidine on the maximal pressure waves.人体十二指肠正常和紊乱的运动模式。左旋莨菪碱、三甲丙咪嗪和雷尼替丁对最大压力波的影响。
Scand J Gastroenterol Suppl. 1981;67:1-3.
9
Measurement of cholecystokinin octapeptide-induced motility of rat antrum, pylorus, and duodenum in vitro.体外测量大鼠胃窦、幽门和十二指肠中胆囊收缩素八肽诱导的运动。
Am J Physiol. 1983 Mar;244(3):G261-5. doi: 10.1152/ajpgi.1983.244.3.G261.
10
Interdigestive and postprandial motility in small-intestinal bacterial overgrowth.小肠细菌过度生长时的消化间期和餐后运动
Scand J Gastroenterol. 1996 Sep;31(9):875-80. doi: 10.3109/00365529609051995.

引用本文的文献

1
Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.雷尼替丁。对其药效学、药代动力学特性以及在消化性溃疡疾病和其他相关疾病中的治疗应用的最新综述。
Drugs. 1989 Jun;37(6):801-70. doi: 10.2165/00003495-198937060-00003.